National Health Innovation Centre Singapore
The National Health Innovation Centre Singapore provides the publicly-funded clinical research sector of Singapore with translational funding and strategic guidance to accelerate healthcare innovation. Established in 2014, we support the development of innovative technologies and services to improve healthcare delivery and patient care. NHIC funding aims to expedite the translation of an innovation towards a market-ready product (see How we work).
NHIC funding schemes
Our three funding streams are for projects which address an unmet healthcare need and have demonstrated ‘proof-of-principle’ supported by experimental data. Each scheme targets different stages of the innovation development pipeline and all proposals for our funding must address intellectual property management, the commercialisation strategy and public health impact of the innovation. Collaborations with industry are encouraged if they strengthen the proposal.
Innovation to Protect
Funding the patent expenses of a validated innovation
Innovation to Develop
Funding the development of an innovation to a commercialisable endpoint
Innovation to Industry
Co-development of a healthcare innovation with an industry partner